Table of Content

Executive Summary



Chapter 1 – Introduction



Chapter 2 – Trends in cardiovascular dealmaking



2.1. Introduction

2.2. Cardiovascular partnering over the years

2.3. Cardiovascular partnering by deal type

2.4. Cardiovascular partnering by industry sector

2.5. Cardiovascular partnering by stage of development

2.6. Cardiovascular partnering by technology type

2.7. Cardiovascular partnering by therapeutic indication



Chapter 3 – Financial deal terms for cardiovascular partnering



3.1. Introduction

3.2. Disclosed financials terms for cardiovascular partnering

3.3. Cardiovascular partnering headline values

3.4. Cardiovascular deal upfront payments

3.5. Cardiovascular deal milestone payments

3.6. Cardiovascular royalty rates



Chapter 4 – Leading cardiovascular deals and dealmakers



4.1. Introduction

4.2. Most active in cardiovascular partnering

4.3. List of most active dealmakers in cardiovascular

4.4. Top cardiovascular deals by value



Chapter 5 – Cardiovascular contract document directory



5.1. Introduction

5.2. Cardiovascular partnering deals where contract document available



Chapter 6 – Cardiovascular dealmaking by therapeutic target



6.1. Introduction

6.2. Deals by cardiovascular therapeutic target



Deal directory



Deal directory – Cardiovascular deals by company A-Z 2016 to 2023

Deal directory – Cardiovascular deals by technology type 2016 to 2023



Deal type definitions



About Wildwood Ventures



Current Partnering

Current Agreements

Recent report titles from CurrentPartnering



Table of figures



Figure 1: Cardiovascular partnering since 2016

Figure 2: Cardiovascular partnering by deal type since 2016

Figure 3: Cardiovascular partnering by industry sector since 2016

Figure 4: Cardiovascular partnering by stage of development since 2016

Figure 5: Cardiovascular partnering by technology type since 2016

Figure 6: Cardiovascular partnering by indication since 2016

Figure 7: Cardiovascular deals with a headline value

Figure 8: Cardiovascular deals with upfront payment values

Figure 9: Cardiovascular deals with milestone payment

Figure 10: Cardiovascular deals with royalty rates

Figure 11: Active cardiovascular dealmaking activity since 2016

Figure 12: Top cardiovascular deals by value since 2016